Topics:

Oncology and Hematology News and Journal Articles

Aspirin May Lower Risk of Pancreatic Cancer

A new study provides evidence that a daily aspirin may reduce the risk of developing pancreatic cancer.

Recent Content

Results of a head-to-head comparison of first-line treatment of metastatic renal cell carcinoma with the mTOR inhibitor everolimus or VEGF inhibitor sunitinib showed that everolimus did not meet noninferiority requirements as a first-line therapy.

A 3-year pilot program that rewarded oncologists for improving outcomes and efficiency—rather than administering drugs—significantly reduced overall costs without lowering quality of care.

End-of-life care is challenging for even the most seasoned oncologist. Here are five suggestions that can help you better navigate this difficult but critical part of your work.

A 43-year-old black man presents with chest pain and dyspnea. Diagnostic imaging reveals the presence of an anterior mediastinal tumor. Surgical resection of the mass is performed.

A 58-year-old man presents with swelling of the right elbow. Biopsy of the soft tissue is obtained.

How low-risk prostate cancer is managed depends more on the diagnosing physician than the patient’s disease state. Men who were diagnosed by a urologist were more likely to receive a treatment performed by the urologist and more likely to receive a therapy rather than monitoring.

The FDA approved idelalisib (Zydelig) yesterday for the treatment of relapsed chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL), and small lymphocytic lymphoma (SLL).

By clicking Accept, you agree to become a member of the UBM Medica Community.